Form 4: Jazz Pharmaceuticals EVP Neena M Patil Sells 5,000 Ordinary Shares
SEC Form 4 Filing
Neena M Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals plc, sold 5,000 ordinary shares at an average price of $109.65 on May 3, 2024.
Summary
- Neena M Patil, the EVP & Chief Legal Officer of Jazz Pharmaceuticals plc, reported a transaction involving the company's ordinary shares.
- On May 3, 2024, Patil sold 5,000 ordinary shares.
- The shares were sold at a weighted average price of $109.65, with individual sales prices ranging from $109.58 to $109.77.
- Following the transaction, Patil directly owns 36,629 ordinary shares.
- The sale was executed under Transaction Code 'S', indicating a sale on the open market.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and can be driven by various personal financial planning reasons. It's important to consider the overall trend of insider transactions and the company's performance when interpreting such sales.
Stakeholder Impact
- The sale of shares by a company executive could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of transaction: Neena M Patil sold 5,000 ordinary shares. |
| 05/07/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.